Agilus Diagnostics files draft papers with Sebi to raise funds via IPO

Agilus Diagnostics IPO: Agilus Diagnostics Ltd has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO). The maiden public issue is entirely an offer for sale (OFS) of 1.42 crore equity shares by International Finance Corp, NYLIM Jacob Balls India Fund III LLC, and Resurgence PE Investments Ltd, according to the draft red herring prospectus (DRHP).

Since the IPO is entirely an OFS, the entire proceeds will go to the existing shareholders.

Agilus Diagnostics, formerly known as SRL Ltd, is one of the largest diagnostics service providers in terms of number of laboratories and the second largest in terms of revenue from operations in India, as of financial year ended March 31, 2023, according to a Crisil report.

TRENDING NOW

Ambuja Cements completes acquisition of Sanghi Industries at revised offer price of Rs 121.90/share

180% return in 3 months: Do you own this multibagger stock?

Meta to discontinue cross-app communication chats on Instagram

Cyclone hits air services in Vizag, 23 flights cancelled

Mizoram Election Result: Zoramthanga resigns as MNF president after party's poll debacle

SIP Calculator: Need money for daughter's education? This SIP investment formula can help you generate Rs 1 crore

Cyclone Michaung: Chennai floods disrupt business operations; Infosys, HCL Tech, Foxconn, MRF affected

Public Provident Fund (PPF): How Rs 1000 will become Rs 5.16 lakh in PPF investment

21,791 fake GST registrations, suspected tax evasion of Rs 24,000 crore detected in special drive: FM Sitharaman

After a two-day pause, Tata Technologies trades in green again

D-Street Newsmakers: IT stocks, Waaree Renewable, and Sanghvi Movers among 10 stocks that buzzed the most today

Morgan Stanley, Goldman Sachs, and others buy stakes in CAMS; stock hits 52-week high

Dividend stocks: From Coal India to Vedanta, here are 5 large-cap stocks with high dividend yields

Anil Singhvi strategy December 5: Important levels to track in Nifty50, Nifty Bank today

How to ride election results-triggered rally on D-Street? Here is what analysts recommend

As of March 31, 2023, it had a network of 413 laboratories out of which 43 laboratories were accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

The company has an international presence across the Middle East, Sub-Saharan Africa, the Commonwealth of Independent States, and the South Asian Association for Regional Cooperation (SAARC) region.

In Fiscal 2023, it performed 3.9 crore tests and served 1.66 crore patients in India and internationally, as per the draft papers filed on Friday.

ICICI Securities, Axis Capital, and Citigroup Global Markets India are the book-running lead managers to the issue.